| 1 |
中华医学会呼吸病学分会肺栓塞与肺血管病学组，中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会，全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志，2018, 98(14): 1060-1087.
|
| 2 |
袁连方，戴 璇，胡国华，等. 急性肺栓塞的诊断及治疗进展[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(5): 84-87.
|
| 3 |
Konstantinides SV, Barco S, Lankeit M, et al. Management of pulmonary embolism: An update[J]. J Am CollCardiol, 2016, 67(8): 976-990.
|
| 4 |
支立敏，张玉杰，曹大龙，等. 急性肺栓塞45例临床诊治分析[J]. 中华全科医学，2017, 15(8): 1286-1288.
|
| 5 |
Giordano NJ, Jansson PS, Young MN, et al. Epidemiology, pathophysiology，stratification, and natural his-tory of pulmonary embolism[J]. Tech VascIntervRadiol, 2017, 20(3): 135-140.
|
| 6 |
Heit JA, Spencer FA, White RH. The epidemiology of venousthromboembolism[J]. J Thromb Thrombolysis, 2016, 41(1): 13-14.
|
| 7 |
Bell EJ, Lutsey PL, Basu S, et al. Lifetime risk of venous throm-boembolism in two cohort studies[J]. Am J Med, 2016, 129(3): 339.e19-339.e26.
|
| 8 |
Fernandez MM, Hogue S, Preblick R, et al. Review of the costof venous thromboembolism[J]. Clinicoecon Outcomes Res, 2015, 7: 451-462.
|
| 9 |
Giordano NJ, Jansson PS, Young MN, et al. Epidemiology, pathophysiology，stratification, and natural his-tory of pulmonary embolism[J]. Tech VascInterv Radiol, 2017, 20(3): 135-140.
|
| 10 |
Marshall PS, Mathews KS, Siegel MD. Diagnosis and managementof life-threatening pulmonary embolism[J]. J Intensive Care Med, 2011, 26(5): 275-294.
|
| 11 |
Huisman MV, Barco S, Cannegieter SC, et al. Pulmonary embolism[J]. Nat Rev Dis Primers, 2018, 4: 18028.
|
| 12 |
Bělohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonaryembolism[J]. ExpClinCardiol, 2013，18(2): 129-138.
|
| 13 |
中国医药教育协会急诊医学分会，中华医学会急诊医学分会心脑血管学组，急性血栓性疾病急诊专家共识组. 中国急性血栓性疾病抗栓治疗共识[J]. 中国急救医学，2019, 39(6): 501-531.
|
| 14 |
王 峰，张伟华，刘占祥. BNP、TNI水平变化与肺栓塞相关性分析[J]. 国际呼吸杂志，2018, 38(1): 53-55.
|
| 15 |
中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015)[J]. 中华心血管病杂志，2016, 44(3): 197-211.
|
| 16 |
Kearon C, Akl EA, Omelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2): 315, 352.
|
| 17 |
Tahir Tak MD, Swetha K, Umesh S, et al. Acute pulmonary embolism：Contemporary approachto diagnosis, risk-stratification, and management[J]. Int J Angiol, 2019, 28(2): 100-111.
|
| 18 |
Barco S, Vicaut E, Klok FA, et al. Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials[J]. EurRespir J, 2018, 51(1): 1701775.
|
| 19 |
Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis[J]. JAMA, 2014, 311(23): 2414-2421.
|
| 20 |
Kuo WT, Banerjee A, Kim PS, et al. Pulmonary embolism response to fragmentation, em-bolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry[J]. Chest, 2015, 148(3): 667-673.
|
| 21 |
Kucher N, Boekstegers P, Müller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism[J]. Circulation, 2014, 129(4): 479-486.
|